PE anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M170_PE_042706
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram) (gated on total cells).
  • M170_PE_042706
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram) (gated on total cells).
  • M170_PE_CD11b_Antibody_IHC_031413
    Fixed whole mount mouse spleen was stained with Alexa Fluor® 488 F4/80 (red) (clone BM8), Brilliant Violet 421™ CD3ε (green) (clone 145-2C11), and PE CD11b (blue) (clone M1/70). Isotype controls at the same concentrations were used for the negative control. Cells were mounted in Prolong Gold and imaged with a Leica SP8 confocal. Image courtesy of Grzegorz Chodaczek and Zbigniew Mikulski at LIAI.
Compare all formats See PE spectral data See more IHC data...
Cat # Size Price Quantity Check Availability Save
101207 50 µg 45€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101208 200 µg 139€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/mL
Storage & Handling
The CD11b antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
IHC - Verified

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Ho YH, et al. 2019. Cell Stem Cell. 25:407. PubMed
  2. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  3. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  4. Li A, et al. 2020. Oncol Lett. 1.899305556. PubMed
  5. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  6. Chida J, et al. 2020. PLoS Pathog. 16:e1008823. PubMed
  7. Guo Y, et al. 2021. Exp Ther Med. 353:21. PubMed
  8. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  9. Kuo PC, et al. 2021. Brain Commun. 3:fcab187. PubMed
  10. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  11. Nigam S, et al. 2020. Mol Imaging Biol. 22:685. PubMed
  12. Hu K, et al. 2022. J Extracell Vesicles. 11:e12199. PubMed
  13. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  14. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  15. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  16. Bhatt K, et al. 2018. mSphere. 3:e00352. PubMed
  17. Baryawno N et al. 2019. Cell. 177(7):1915-1932 . PubMed
  18. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  19. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  20. Prajeeth C,et al. 2017. J Neuroinflammation.. 10.1186/s12974-017-0978-3. PubMed
  21. Lei G, et al. 2016. Antimicrob Agents Chemother. 60: 1289 - 1297. PubMed
  22. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  23. Yan F, et al. 2022. Cancer Discov. 12:792. PubMed
  24. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  25. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  26. Deng Y, et al. 2021. Acta Pharmacol Sin. 42:149. PubMed
  27. Pan J, et al. 2021. Mol Ther Nucleic Acids. 26:970. PubMed
  28. Gonçalves NP, et al. 2017. J Neuroinflammation. 14:115. PubMed
  29. Yamauchi T et al. 2018. Cancer cell. 33(3):386-400 . PubMed
  30. Xiao X, et al. 2020. J Hematol Oncol. 0.597222222. PubMed
  31. Elkabets M, et al. 2009. J Immunol. 182:4874. PubMed
  32. Li X, et al. 2015. Proc Natl Acad Sci U S A. 112:6080. PubMed
  33. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  34. Dumas SJ, et al. 2021. STAR Protocols. 2(3):100523. PubMed
  35. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  36. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  37. Conforti A, et al. 2021. PLoS One. 16:e0259894. PubMed
  38. Götz P, et al. 2022. Int J Mol Sci. 23:. PubMed
  39. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  40. Hiraishi Y, et al. 2018. Sci Rep. 8:18052. PubMed
  41. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  42. Llewellyn GN, et al. 2018. J Neurovirol. 24:192. PubMed
  43. Sun Y et al. 2018. Cancer cell. 34(4):643-658 . PubMed
  44. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  45. Earnest JT, et al. 2021. Cell Reports. 35(1):108962. PubMed
  46. Jard T, et al. 2020. Cell Stem Cell. 27(4):646-662.e7. PubMed
  47. Forte D, et al. 2020. Cell Metab. 32:829. PubMed
  48. Coppo M, et al. 2016. Nat Commun. 7:12254. PubMed
  49. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  50. Shears RK, et al. 2020. J Allergy Clin Immunol. 145:1272. PubMed
  51. Chen X, et al. 2021. Cell Death Differ. 28:1237. PubMed
  52. Stolp B, et al. 2022. Cell Rep. 38:110387. PubMed
  53. Craver BM, et al. 2020. Blood Adv. 4:312. PubMed
  54. Turkowski K, et al. 2017. Glia. 10.1002/glia.23234. PubMed
  55. Wiese A, et al. 2017. PLoS One. 10.1371/journal.pone.0184956. PubMed
  56. Hengyou Weng et al. 2018. Cell stem cell. 22(2):191-205 . PubMed
  57. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  58. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  59. Ganeshan K et al. 2019. Cell. 177(2):399-413 . PubMed
  60. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  61. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  62. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  63. Price J, et al. 2015. Diabetes. 64: 3521 - 3531. PubMed
  64. Kalucka J, et al. 2020. Cell. 764:180. PubMed
  65. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  66. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  67. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  68. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  69. Chen F, et al. 2022. Evid Based Complement Alternat Med. 2022:1240242. PubMed
  70. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  71. Pan J, et al. 2020. J Neuroinflammation. 17:97. PubMed
  72. Paraiso HC, et al. 2018. J Neuroinflammation. 0.694444444. PubMed
  73. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  74. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  75. Hammond TR, et al. 2019. Immunity. 50:253. PubMed
  76. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  77. Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed
  78. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  79. Endo Y, et al. 2020. FASEB J. 34:16086. PubMed
  80. Diao N, et al. 2016. Sci Rep. 6:34672. PubMed
  81. Huang L, et al. 2016. J Biol Chem. 291: 6232 - 6244. PubMed
  82. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  83. Li K, et al. 2022. J Immunother Cancer. 10:. PubMed
  84. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  85. Rogawski DS, et al. 2021. Nat Commun. 12:2792. PubMed
  86. Trenevska I, et al. 2021. PLoS One. 16:e0249967. PubMed
  87. Gordon RA, et al. 2020. PLoS One. 15:e0226396. PubMed
  88. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  89. An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed
  90. Wang L, et al. 2017. Front Immunol.. 10.3389/fimmu.2017.01754. PubMed
  91. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  92. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  93. Zhang S, et al. 2019. Mol Med Rep. 19:5377. PubMed
  94. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  95. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  96. Nakaya M, et al. 2017. J Clin Invest. 127:383. PubMed
  97. Mayo L, et al. 2008. J Immunol. 181:92. PubMed
  98. Xiao Z, et al. 2015. Cancer Lett. 360:302. PubMed
  99. Donley DW, et al. 2021. PLOS ONE. 16(5):e0250606. PubMed
  100. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  101. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  102. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  103. Zheng Y, et al. 2022. Front Pharmacol. 12:816032. PubMed
  104. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  105. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  106. Zhang X, et al. 2022. Cells. 11:. PubMed
  107. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  108. Keshavarz M, et al. 2020. Virol J. 17:64. PubMed
  109. He L, et al. 2019. iScience. 0.790972222. PubMed
  110. Frazier T, et al. 2018. Adipocyte. 0.41875. PubMed
  111. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  112. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  113. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  114. Jin R, et al. 2020. Mol Cancer Ther. . PubMed
  115. Nguyen TKT, et al. 2020. Am J Pathol. 286:190. PubMed
  116. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  117. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  118. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  119. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  120. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  121. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  122. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  123. Hou M, et al. 2020. Stem Cell Res Ther. 11:55. PubMed
  124. Jaworska K, et al. 2015. J Immunol. 194:325. PubMed
  125. Chen Y, et al. 2015. PLoS One. 10: 0135217. PubMed
  126. Li L, et al. 2015. J Am Soc Nephrol. 26: 2183-2197. PubMed
  127. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  128. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  129. Hildebrand KM, et al. 2021. PLoS One. 16:e0253864. PubMed
  130. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  131. Malekghasemi S, et al. 2020. Cell Biol Int. 44:2031. PubMed
  132. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  133. Luong-Gardiol N, et al. 2019. Cancer Cell. 35:649. PubMed
  134. Murray C, et al. 2018. Lab Chip. 18:2396. PubMed
  135. Han D, et al. 2021. J Immunol Res. 6688053:2021. PubMed
  136. Nguyen GT, et al. 2021. iScience. 24(8):102871. PubMed
  137. Garg M, et al. 2021. Cell Reports. 34(6):108736. PubMed
  138. Cao DY, et al. 2020. J Biol Chem. 295:1369. PubMed
  139. Moorlag SJCFM, et al. 2020. Cell Rep. 33:108387. PubMed
  140. Koshida R, et al. 2015. Biochem Biophys Res Commun. 463: 109-115. PubMed
  141. Textor A, et al. 2014. Cancer Res. 74:6769. PubMed
  142. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  143. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  144. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  145. Lin S, et al. 2022. Nat Commun. 13:3301. PubMed
  146. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  147. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  148. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  149. He J, et al. 2019. J Clin Invest. 130. PubMed
  150. Huang Y, et al. 2019. Cancer Cell. 35:677. PubMed
  151. Ruiz de Azua I, et al. 2017. J Clin Invest. 127:4148. PubMed
  152. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  153. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  154. Kan X, et al. 2015. Cardiovasc Res. 10.1093/cvr/cvv255. PubMed
  155. Mizuno T, et al. 2017. Sci Rep. 7:42714. PubMed
  156. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  157. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  158. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  159. Yang Y, et al. 2022. Elife. 11:. PubMed
  160. Bolkhovitina EL, et al. 2022. Int J Mol Sci. 23:. PubMed
  161. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  162. Staschke K, et al. 2009. J Immunol. 183:568. PubMed
  163. Challa TD, et al. 2020. Cell Reports. 30(10):3424-3433. PubMed
  164. Minuesa G, et al. 2019. Nat Commun. 10:2691. PubMed
  165. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  166. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  167. Wang Q, et al. 2018. Int J Biol Sci. 14:147. PubMed
  168. Koikawa K, et al. 2021. Cell. 184(18):4753-4771.e27. PubMed
  169. Sokol L, et al. 2021. STAR Protocols. 2(2):100489. PubMed
  170. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  171. Troutman TD, et al. 2021. STAR Protocols. 2(1):100363. PubMed
  172. Wang L, et al. 2012. PLoS One. 7:e40056. PubMed
  173. Perez-Garcia CG, et al. 2022. Mol Ther Nucleic Acids. 28:87. PubMed
  174. Uslu M, et al. 2020. J Cell Physiol. 235:9644. PubMed
  175. Zhai K, et al. 2021. Nat Cancer. 2:1136. PubMed
  176. Chiang HY, et al. 2022. Nat Commun. 13:874. PubMed
  177. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  178. Bermejo-Jambrina M, et al. 2021. EMBO J. 40:e106765. PubMed
  179. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  180. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  181. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  182. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  183. Gomez–Ospina N, et al. 2019. Nat Commun. 3.225694444. PubMed
  184. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  185. Tan S, et al. 2006. J Immunol. 176:2872. PubMed
  186. Langhauser F, et al. 2014. Stroke. 45:1799. PubMed
  187. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  188. Favuzzi E, et al. 2021. Cell. 184(15):4048-4063.e32. PubMed
  189. Roy AG, et al. 2021. Int J Mol Sci. 22:. PubMed
  190. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  191. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  192. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  193. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
  194. Babagana M, et al. 2021. Aging (Albany NY). 13:19207. PubMed
  195. Li Q, et al. 2022. Front Cardiovasc Med. 9:872102. PubMed
  196. Dungan CM, et al. 2022. Aging Cell. 21:e13528. PubMed
  197. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  198. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  199. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  200. Luck H, et al. 2019. Nat Commun. 10:3650. PubMed
  201. Xiao G, et al. 2018. Cell. 173:470. PubMed
  202. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  203. Wu ZJ, et al. 2018. Int J Oncol. 52:1209. PubMed
  204. Li T, et al. 2021. J Neuroinflammation. 81:18. PubMed
  205. Guo M, et al. 2020. Brain. 1476:143. PubMed
  206. Houben T, et al. 2020. J Pathol. 251:429. PubMed
  207. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  208. Li L, et al. 2014. J Immunol. 192:1034. PubMed
  209. Demers M, et al. 2012. Proc Natl Acad Sci U S A. 109:13076. PubMed
  210. Szeifert V, et al. 2021. Front Immunol. 12:671995. PubMed
  211. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  212. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  213. Cao W, et al. 2021. Int J Mol Sci. 22:. PubMed
  214. Calle P, et al. 2021. Cells. 10:. PubMed
  215. Bennett FC, et al. 2018. Neuron. 98:1170. PubMed
  216. Zhang T, et al. 2018. PLoS One. 13:e0196571. PubMed
  217. Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed
  218. Cá B, et al. 2019. Front Microbiol. 1.876388889. PubMed
  219. Ding H, et al. 2016. Nat Commun. 7:11533. PubMed
  220. Yuan Y, et al. 2020. Front Physiol. 0.967361111. PubMed
  221. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  222. Toyohara T, et al. 2020. Cell Stem Cell. 27:147. PubMed
  223. Dong Y, et al. 2021. Commun Biol. 4:560. PubMed
  224. Scheiblich H, et al. 2021. Cell. 184:5089. PubMed
  225. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  226. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  227. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  228. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  229. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  230. Lin KH, et al. 2020. Nat Genet. 52:408. PubMed
  231. Jablonski K, et al. 2015. PLoS One. 10: 0145342. PubMed
  232. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  233. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  234. Resende M, et al. 2013. J Immunol. 191:262. PubMed
  235. Gerdes P, et al. 2022. Nat Commun. 13:7470. PubMed
  236. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  237. Wang X, et al. 2021. Cell. 184:5357. PubMed
  238. Li Y, et al. 2020. Theranostics. 10:2897. PubMed
  239. Xia D, et al. 2022. Mol Neurodegener. 17:41. PubMed
  240. Koide S, et al. 2022. iScience. 25:103603. PubMed
  241. Lin T, et al. 2021. PLoS Pathog. 17:e1009557. PubMed
  242. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  243. Wang Z et al. 2019. Cell reports. 26(5):1273-1285 . PubMed
  244. Schaftenaar FH, et al. 2019. Sci Rep. 9:17391. PubMed
  245. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  246. Nguyen GT, et al. 2020. eLife. 9:e56656.. PubMed
  247. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  248. Kuo P, et al. 2016. J Am Heart Assoc. 5: 002610. PubMed
  249. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  250. Avalle L, et al. 2020. Mol Ther Methods Clin Dev. 0.793055556. PubMed
  251. Zhou Q, et al. 2020. Nat Immunol. 1.393055556. PubMed
  252. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  253. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  254. Zhang A, et al. 2021. Theranostics. 11:3839. PubMed
  255. Zhai T, et al. 2020. Clin Exp Pharmacol Physiol. 47:677. PubMed
  256. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  257. Schmidt C, et al. 2005. J Immunol. 175:2286. PubMed
  258. Danne C et al. 2017. Cell host & microbe. 22(6):733-745 . PubMed
  259. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  260. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  261. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  262. Baruch K, et al. 2015. EMBO J. 34: 1816 - 1828. PubMed
  263. Bozoglu T, et al. 2022. Adv Sci (Weinh). 9:e2103867. PubMed
  264. Shen H, et al. 2022. Nat Commun. 13:5013. PubMed
  265. Zhang X, et al. 2022. J Exp Clin Cancer Res. 41:246. PubMed
  266. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  267. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  268. Bahmani B, et al. 2021. Nat Commun. 12:1999. PubMed
  269. Fielding C, et al. 2022. Nat Commun. 13:543. PubMed
  270. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  271. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  272. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  273. Zhang M, et al. 2019. Autophagy. 1.423611111. PubMed
  274. Hirako N, et al. 2014. PLoS One. 9:103282. PubMed
  275. Chen Z, et al. 2016. Innate Immunity. 22: 419 - 432. PubMed
  276. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  277. Evavold CL, et al. 2021. Cell. 184(17):4495-4511.e19. PubMed
  278. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  279. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  280. Henkle TR, et al. 2021. Cancer Res. 81:4560. PubMed
  281. Gawish R, et al. 2022. Elife. 11:. PubMed
  282. Wang T, et al. 2022. Int J Nanomedicine. 17:2191. PubMed
  283. Cai W, et al. 2019. J Neuroinflammation. 0.788194444. PubMed
  284. Fernando N, et al. 2020. Front Cell Dev Biol. 0.691666667. PubMed
  285. Dougan M, et al. 2018. Cancer Immunol Res. 6:389. PubMed
  286. Abdel Malik R, et al. 2017. Circ Res. 120:99. PubMed
  287. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
  288. Wong PP, et al. 2020. Cell. 181(6):1346-1363.e21. PubMed
  289. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  290. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  291. K K, et al. 2016. Haematologica. 151159. PubMed
  292. Han J, et al. 2015. Cancer Res . 75: 5273 - 5282. PubMed
  293. Saber M, et al. 2021. J Neurotrauma. 38:2862. PubMed
  294. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  295. Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed
  296. Steinmetz TD, et al. 2021. Autophagy. 17:2238. PubMed
  297. Hohsfield LA, et al. 2021. Elife. 10:. PubMed
  298. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  299. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  300. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  301. Rana MN, et al. 2021. Front Pharmacol. 12:643215. PubMed
RRID
AB_312790 (BioLegend Cat. No. 101207)
AB_312791 (BioLegend Cat. No. 101208)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC, IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC, CyTOF®, IP, IHC-F, ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC, IHC-F, 3D IHC, SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC, 3D IHC
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC, ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC, CyTOF®, IP, Block, Depletion, IHC-F, ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC, CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F, FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 2    Revision Date: 03-14-2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse/human CD11b

  • Biotin anti-mouse/human CD11b

  • FITC anti-mouse/human CD11b

  • PE anti-mouse/human CD11b

  • PE/Cyanine5 anti-mouse/human CD11b

  • Purified anti-mouse/human CD11b

  • PE/Cyanine7 anti-mouse/human CD11b

  • Alexa Fluor® 488 anti-mouse/human CD11b

  • Alexa Fluor® 647 anti-mouse/human CD11b

  • Alexa Fluor® 700 anti-mouse/human CD11b

  • Pacific Blue™ anti-mouse/human CD11b

  • APC/Cyanine7 anti-mouse/human CD11b

  • PerCP/Cyanine5.5 anti-mouse/human CD11b

  • PerCP anti-mouse/human CD11b

  • Brilliant Violet 421™ anti-mouse/human CD11b

  • Brilliant Violet 570™ anti-mouse/human CD11b

  • Brilliant Violet 605™ anti-mouse/human CD11b

  • Brilliant Violet 650™ anti-mouse/human CD11b

  • Brilliant Violet 711™ anti-mouse/human CD11b

  • Brilliant Violet 785™ anti-mouse/human CD11b

  • Brilliant Violet 510™ anti-mouse/human CD11b

  • Ultra-LEAF™ Purified anti-mouse/human CD11b

  • Purified anti-mouse/human CD11b (Maxpar® Ready)

  • Alexa Fluor® 594 anti-mouse/human CD11b

  • PE/Dazzle™ 594 anti-mouse/human CD11b

  • APC/Fire™ 750 anti-mouse/human CD11b

  • TotalSeq™-A0014 anti-mouse/human CD11b

  • Brilliant Violet 750™ anti-mouse/human CD11b

  • TotalSeq™-B0014 anti-mouse/human CD11b

  • TotalSeq™-C0014 anti-mouse/human CD11b

  • Spark NIR™ 685 anti-mouse/human CD11b

  • PE/Fire™ 640 anti-mouse/human CD11b

  • Spark YG™ 593 anti-mouse/human CD11b

  • Spark YG™ 570 anti-mouse/human CD11b

  • PE/Fire™ 810 anti-mouse/human CD11b

  • APC/Fire™ 810 anti-mouse/human CD11b Antibody

  • Spark Blue™ 550 anti-mouse/human CD11b

  • Spark UV™ 387 anti-mouse/human CD11b

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account